SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
Initial Data From Aastrom Biosciences, Inc.'s IMPACT-DCM Trial Presented At International Society for Cellular Therapy Annual Meeting by Amit N. Patel, M.D.